Aizon
Aizon is a software-as-a-service company that provides AI-powered solutions for GxP pharmaceutical manufacturing. Their platform aims to improve yield, reduce deviations, and ensure product quality by leveraging real-time data and predictive analytics. Aizon's solutions are designed to be adapted to specific needs, with a consulting service that can accelerate results within six weeks. The company targets quality, production, and tech ops leaders, as well as corporate functions, to optimize manufacturing activities and deliver drugs on time and budget. Key products include Aizon Execute for recipe execution, Aizon Unify for data lakehouse and batch review, and Aizon Predict for yield optimization.
Aizon
Aizon is a software-as-a-service company that provides AI-powered solutions for GxP pharmaceutical manufacturing. Their platform aims to improve yield, reduce deviations, and ensure product quality by leveraging real-time data and predictive analytics. Aizon's solutions are designed to be adapted to specific needs, with a consulting service that can accelerate results within six weeks. The company targets quality, production, and tech ops leaders, as well as corporate functions, to optimize manufacturing activities and deliver drugs on time and budget. Key products include Aizon Execute for recipe execution, Aizon Unify for data lakehouse and batch review, and Aizon Predict for yield optimization.
TL;DR
What they do: AI-powered SaaS for GxP pharmaceutical and biotech manufacturing analytics
Headquarters: San Francisco, California
Recent funding: Closed $20M Series C (Feb 2024)
Founders: Pep Gubau, Pere Merino, Toni Manzano
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
GxP pharmaceutical and biotech manufacturing operations, quality assurance, and production optimization
Founded
2014
Industry
IT Services and IT Consulting
Funding Track Record
15000000
Company announced $15M Series B
20000000
Company announced $20M Series C
Investor Signal
“Continued participation from institutional investors including Atlantic Bridge, Crosslink Capital and Uncork Capital; Series C led by NewVale Capital”